Michael Steinmetz - Net Worth and Insider Trading
Michael Steinmetz Net Worth
The estimated net worth of Michael Steinmetz is at least $3 Million dollars as of 2024-12-28. Michael Steinmetz is the 10% Owner of Rigel Pharmaceuticals Inc and owns about 183,360 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $3 Million. Michael Steinmetz is also the Director of Acorda Therapeutics Inc and owns about 15,057 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $203. Details can be seen in Michael Steinmetz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Steinmetz has not made any transactions after 2006-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Steinmetz
Michael Steinmetz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Steinmetz owns 20 companies in total, including Radius Health Inc (RDUS) , TetraLogic Pharmaceuticals Corp (TLOG) , and IVERIC bio Inc (ISEE) among others .
Click here to see the complete history of Michael Steinmetz’s form 4 insider trades.
Insider Ownership Summary of Michael Steinmetz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RDUS | Radius Health Inc | 2011-05-17 | 10 percent owner |
| TLOG | TetraLogic Pharmaceuticals Corp | 2016-02-08 | 10 percent owner |
| ISEE | IVERIC bio Inc | 2013-09-25 | 10 percent owner |
 | | 2013-10-25 | 10 percent owner |
| | 2013-11-21 | director & 10 percent owner |
| | 2012-08-02 | other: Managing dir. of GP |
| | 2012-08-11 | 10 percent owner |
| | 2012-06-04 | 10 percent owner |
| | 2011-10-27 | 10 percent owner |
| | 2011-09-16 | 10 percent owner |
| | 2010-12-14 | other: Former 10% Owner |
| | 2007-08-03 | other: See explanation below |
| | 2010-09-30 | 10 percent owner |
| | 2010-03-11 | 10 percent owner |
| | 2010-01-27 | 10 percent owner |
| | 2009-11-05 | 10 percent owner |
| | 2006-12-19 | 10 percent owner |
| | 2006-02-15 | director |
| | 2004-08-02 | 10 percent owner |
| | 2004-03-10 | 10 percent owner |
Michael Steinmetz Latest Holdings Summary
Michael Steinmetz currently owns a total of 2 stocks. Among these stocks, Michael Steinmetz owns 183,360 shares of Rigel Pharmaceuticals Inc (RIGL) as of August 2, 2004, with a value of $3 Million and a weighting of 99.99%. Michael Steinmetz also owns 15,057 shares of Acorda Therapeutics Inc (ACORQ) as of February 15, 2006, with a value of $203 and a weighting of 0.01%.
Latest Holdings of Michael Steinmetz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2004-08-02 | 183,360 | 16.50 | 3,025,440 |
| ACORQ | Acorda Therapeutics Inc | 2006-02-15 | 15,057 | 0.01 | 203 |
Holding Weightings of Michael Steinmetz
Michael Steinmetz Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Steinmetz has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 197 shares on August 2, 2004, which brought Michael Steinmetz around $36,762.
According to the SEC Form 4 filings, Michael Steinmetz has made a total of 0 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years. The most-recent trade in Acorda Therapeutics Inc is the acquisition of 1,389 shares on February 15, 2006, which cost Michael Steinmetz around $1,000,000.
Insider Trading History of Michael Steinmetz
- 1
Michael Steinmetz Trading Performance
GuruFocus tracks the stock performance after each of Michael Steinmetz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Steinmetz is -23.51%. GuruFocus also compares Michael Steinmetz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Steinmetz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Steinmetz's insider trading performs compared to the benchmark.
Performance of Michael Steinmetz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.64 | | | | | |
| Relative Return to S&P 500(%) | -5.44 | | | | | |
Michael Steinmetz Ownership Network
Michael Steinmetz Owned Company Details
What does Radius Health Inc do?
Who are the key executives at Radius Health Inc?
Michael Steinmetz is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .
Radius Health Inc (RDUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Radius Health Inc Insider Transactions
Michael Steinmetz Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Steinmetz. You might contact Michael Steinmetz via mailing address: The John Hancock Tower, 200 Clarendon Street, 54th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
